Janux Therapeutics Inc

XNAS:JANX

14.94

+0.36 (+2.47%)

6:21:31 PM EDT: $14.56 -0.38 (-2.53%)

Market Cap (Intraday)	911.12M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$19.07 Million
Adjusted EPS	-$0.25

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Janux Therapeutics Inc Stock, XNAS:JANX

10955 Vista Sorrento Parkway, Suite 200, San Diego, California 92130

United States of America

Phone: +1.858.751.4493

Number of Employees: 81

http://www.januxrx.com

Description

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in San Diego, CA.